Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABA<sub>A</sub> receptor encephalitis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33619082.
- Also identified by DOI 10.1073/pnas.1916337118 and PMC identifier 7936355.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Encephalitis associated with antibodies against the neuronal gamma-aminobutyric acid A receptor (GABA<sub>A</sub>-R) is a rare form of autoimmune encephalitis. The pathogenesis is still unknown but autoimmune mechanisms were surmised. Here we identified a strongly expanded B cell clone in the cerebrospinal fluid of a patient with GABA<sub>A</sub>-R encephalitis. We expressed the antibody produced by it and showed by enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry that it recognizes the GABA<sub>A</sub>-R. Patch-clamp recordings revealed that it tones down inhibitory synaptic transmission and causes increased excitability of hippocampal CA1 pyramidal neurons. Thus, the antibody likely contributed to clinical disease symptoms. Hybridization to a protein array revealed the cross-reactive protein LIM-domain-only protein 5 (LMO5), which is related to cell-cycle regulation and tumor growth. We confirmed LMO5 recognition by immunoprecipitation and ELISA and showed that cerebrospinal fluid samples from two other patients with GABA<sub>A</sub>-R encephalitis also recognized LMO5. This suggests that cross-reactivity between GABA<sub>A</sub>-R and LMO5 is frequent in GABA<sub>A</sub>-R encephalitis and supports the hypothesis of a paraneoplastic etiology.
Medical subject headings
- Antigens, Neoplasm
- Autoantibodies
- Cross Reactions
- Disease Susceptibility
- Encephalitis
- Receptors, GABA-A